In no instances did CLL cells express higher levels of HLA-A/B/C than the corresponding CD8+ cells, validating the use of CD8+ cells as appropriate alloantigen controls (data not shown). This evidence concerns the gene HLA-A and B-cell chronic lymphocytic leukemia.